Creative Medical Technology Holdings, Inc. Research and Development Expense
Creative Medical Technology Holdings, Inc. (CELZ) reported Research and Development Expense of $459.20 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-07
- Creative Medical Technology Holdings, Inc. research and development expense for the quarter ending 2026-06-30 was $459.20K, a 8.39% decline year-over-year.
- Creative Medical Technology Holdings, Inc. research and development expense for the quarter ending 2026-03-31 was $541.66K, a 27.13% decline year-over-year.
- Creative Medical Technology Holdings, Inc. research and development expense for the quarter ending 2025-12-31 was $550.08K, a 16.58% increase year-over-year.
- Creative Medical Technology Holdings, Inc. research and development expense for the quarter ending 2025-09-30 was $465.15K, a 20.05% decline year-over-year.
- Creative Medical Technology Holdings, Inc. research and development expense for fiscal 2025 was $2.26M, a 5.87% decline from fiscal 2024.
- Creative Medical Technology Holdings, Inc. research and development expense for fiscal 2024 was $2.40M, a 21.83% increase from fiscal 2023.
- Creative Medical Technology Holdings, Inc. research and development expense for fiscal 2023 was $1.97M, a 68.56% decline from fiscal 2022.
- Creative Medical Technology Holdings, Inc. research and development expense for fiscal 2022 was $6.27M, a 5641.76% increase from fiscal 2021.
| Period end | Research and Development Expense 0 month | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $459.20K 10-Q · filed 2026-08-07 | $1.00M 10-Q · filed 2026-08-07 | $1.55M derived: sum of 3 quarters · filed 2026-08-07 | $2.02M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | $541.66K 10-Q · filed 2026-05-08 | $1.09M derived: sum of 2 quarters · filed 2026-05-08 | $1.56M derived: sum of 3 quarters · filed 2026-05-08 | $2.06M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-12-31 | $550.08K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | $1.02M derived: sum of 2 quarters · filed 2026-03-20 | $1.52M derived: sum of 3 quarters · filed 2026-08-07 | $2.26M 10-K · filed 2026-03-20 | |
| 2025-09-30 | $465.15K 10-Q · filed 2025-11-07 | $966.41K derived: sum of 2 quarters · filed 2026-08-07 | $1.71M 10-Q · filed 2025-11-07 | $2.18M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-06-30 | $501.26K 10-Q · filed 2026-08-07 | $1.24M 10-Q · filed 2026-08-07 | $1.72M derived: sum of 3 quarters · filed 2026-08-07 | $2.30M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-03-31 | $743.30K 10-Q · filed 2026-05-08 | $1.22M derived: sum of 2 quarters · filed 2026-05-08 | $1.80M derived: sum of 3 quarters · filed 2026-05-08 | $2.72M derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | $471.84K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | $1.05M derived: sum of 2 quarters · filed 2026-03-20 | $1.98M derived: sum of 3 quarters · filed 2026-03-20 | $2.40M 10-K · filed 2026-03-20 | |
| 2024-09-30 | $581.80K 10-Q · filed 2025-11-07 | $1.51M derived: sum of 2 quarters · filed 2025-11-07 | $1.93M 10-Q · filed 2025-11-07 | $2.28M derived: sum of 4 quarters · filed 2025-11-07 | |
| 2024-06-30 | $924.75K 10-Q · filed 2025-08-08 | $1.35M 10-Q · filed 2025-08-08 | $1.70M derived: sum of 3 quarters · filed 2025-08-08 | $2.69M derived: sum of 4 quarters · filed 2025-08-08 | |
| 2024-03-31 | $422.39K 10-Q · filed 2025-05-09 | $771.80K derived: sum of 2 quarters · filed 2025-05-09 | $1.76M derived: sum of 3 quarters · filed 2025-05-09 | $2.07M derived: sum of 4 quarters · filed 2025-05-09 | |
| 2023-12-31 | $349.41K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $1.34M derived: sum of 2 quarters · filed 2025-03-14 | $1.65M derived: sum of 3 quarters · filed 2025-03-14 | $1.97M 10-K · filed 2025-03-14 | |
| 2023-09-30 | $992.72K 10-Q · filed 2024-11-08 | $1.30M derived: sum of 2 quarters · filed 2024-11-08 | $1.62M 10-Q · filed 2024-11-08 | $6.99M derived: sum of 4 quarters · filed 2024-11-08 | |
| 2023-06-30 | $309.48K 10-Q · filed 2024-08-09 | $628.51K 10-Q · filed 2024-08-09 | $6.00M derived: sum of 3 quarters · filed 2024-08-09 | $6.23M derived: sum of 4 quarters · filed 2024-08-09 | |
| 2023-03-31 | $319.03K 10-Q · filed 2024-05-10 | $5.69M derived: sum of 2 quarters · filed 2024-05-10 | $5.92M derived: sum of 3 quarters · filed 2024-05-10 | $6.58M derived: sum of 4 quarters · filed 2024-05-10 | |
| 2023-03-15 | $5.00M 10-K · filed 2024-03-22 | ||||
| 2022-12-31 | $5.37M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $5.60M derived: sum of 2 quarters · filed 2024-03-22 | $6.26M derived: sum of 3 quarters · filed 2024-03-22 | $6.27M 10-K · filed 2024-03-22 | |
| 2022-12-15 | $5.00M 10-Q · filed 2023-11-14 | ||||
| 2022-09-30 | $230.94K 10-Q · filed 2023-11-14 | $890.63K derived: sum of 2 quarters · filed 2023-11-14 | $900.63K 10-Q · filed 2023-11-14 | $950.63K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $659.70K 10-Q · filed 2023-08-11 | $669.70K 10-Q · filed 2023-08-11 | $719.70K derived: sum of 3 quarters · filed 2023-08-11 | $778.88K derived: sum of 4 quarters · filed 2023-08-11 | |
| 2022-03-31 | $10.00K 10-Q · filed 2023-05-12 | $60.00K derived: sum of 2 quarters · filed 2023-05-12 | $119.18K derived: sum of 3 quarters · filed 2023-05-12 | $119.18K derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | $50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $109.18K derived: sum of 2 quarters · filed 2023-03-31 | $109.18K derived: sum of 3 quarters · filed 2023-03-31 | $109.18K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $59.18K 10-Q · filed 2022-11-10 | $59.18K derived: sum of 2 quarters · filed 2022-11-10 | $59.18K 10-Q · filed 2022-11-10 | $59.18K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | $0.00 derived: sum of 3 quarters · filed 2022-08-12 | $0.00 derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-13 | $0.00 derived: sum of 2 quarters · filed 2022-05-13 | $0.00 derived: sum of 3 quarters · filed 2022-05-13 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $0.00 derived: sum of 2 quarters · filed 2022-03-30 | $0.00 10-K · filed 2022-03-30 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $0.00 derived: sum of 2 quarters · filed 2021-03-17 | $0.00 derived: sum of 3 quarters · filed 2021-03-17 | $0.00 10-K · filed 2021-03-17 | |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2019-11-14 | $0.00 10-Q · filed 2019-11-14 | $86.34K derived: sum of 4 quarters · filed 2020-04-06 | |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-13 | $0.00 10-Q · filed 2019-08-13 | $86.34K derived: sum of 3 quarters · filed 2020-04-06 | $89.22K derived: sum of 4 quarters · filed 2020-04-06 | |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-20 | $86.34K derived: sum of 2 quarters · filed 2020-04-06 | $89.22K derived: sum of 3 quarters · filed 2020-04-06 | $93.42K derived: sum of 4 quarters · filed 2020-04-06 | |
| 2018-12-31 | $86.34K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-06 | $89.22K derived: sum of 2 quarters · filed 2020-04-06 | $93.42K derived: sum of 3 quarters · filed 2020-04-06 | $96.62K 10-K · filed 2020-04-06 | |
| 2018-09-30 | $2.88K 10-Q · filed 2019-11-14 | $7.08K derived: sum of 2 quarters · filed 2019-11-14 | $10.28K 10-Q · filed 2019-11-14 | $97.62K derived: sum of 4 quarters · filed 2019-11-14 | |
| 2018-06-30 | $4.20K 10-Q · filed 2019-08-13 | $7.40K 10-Q · filed 2019-08-13 | $94.74K derived: sum of 3 quarters · filed 2019-08-13 | $182.47K derived: sum of 4 quarters · filed 2019-08-13 | |
| 2018-03-31 | $3.20K 10-Q · filed 2019-05-20 | $90.54K derived: sum of 2 quarters · filed 2019-05-20 | $178.26K derived: sum of 3 quarters · filed 2019-05-20 | $203.45K derived: sum of 4 quarters · filed 2019-05-20 | |
| 2017-12-31 | $87.34K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $175.06K derived: sum of 2 quarters · filed 2019-04-01 | $200.25K derived: sum of 3 quarters · filed 2019-04-01 | $260.08K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $87.73K 10-Q · filed 2018-11-14 | $112.92K derived: sum of 2 quarters · filed 2018-11-14 | $172.75K 10-Q · filed 2018-11-14 | $190.52K derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-06-30 | $25.19K 10-Q · filed 2018-08-14 | $85.02K 10-Q · filed 2018-08-14 | $102.79K derived: sum of 3 quarters · filed 2018-08-14 | $147.96K derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-03-31 | $59.83K 10-Q · filed 2018-08-03 | $77.60K derived: sum of 2 quarters · filed 2018-08-03 | $122.77K derived: sum of 3 quarters · filed 2018-08-03 | $140.80K derived: sum of 4 quarters · filed 2018-08-03 | |
| 2016-12-31 | $17.77K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $62.94K derived: sum of 2 quarters · filed 2018-03-29 | $80.97K derived: sum of 3 quarters · filed 2018-03-29 | $85.33K 10-K · filed 2018-03-29 | |
| 2016-09-30 | $45.17K 10-Q · filed 2017-11-13 | $63.20K derived: sum of 2 quarters · filed 2017-11-13 | $67.57K 10-Q · filed 2017-11-13 | ||
| 2016-06-30 | $18.03K 10-Q · filed 2017-08-14 | $22.39K 10-Q · filed 2017-08-14 | |||
| 2016-03-31 | $4.36K 10-Q · filed 2017-05-10 | ||||
| 2015-12-31 | $0.00 10-K · filed 2017-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |